Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 6, 2009GutOpen Access

Adalimumab for the treatment of fistulas in patients with Crohn’s disease

View Full Paper
Ask AI
Bookmark
Share

Authors

JCJ F ColombelIcahn School of Medicine at Mount SinaiDSDavid A. SchwartzRED Consulting (Norway)
William J. Sandborn
William J. SandbornSemmelweis University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Colombel et al. (2009) studied this question.

synapsesocial.com/papers/69d8ace78c03fbaff8befddehttps://doi.org/10.1136/gut.2008.159251
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1An Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Prior Loss of Response or Intolerance to Infliximab for Crohn's Disease2004 · 279 citations
  2. 2Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial2007 · 1,042 citations
  3. 3Infliximab Maintenance Therapy for Fistulizing Crohn's Disease2004 · 2,229 citations